Skip to main content
High RiskFDAfda-F-2321-2014OTHER

Part Skim Ricotta cheese: SYSCO Imperial Ricotta Cheese packaged in 5 pound tubs and Sargento Part-Skim Ricotta Natural Cheese and Miceli...

Category
Units Affected
357
Recall Date
June 19, 2014
Issuing Agency
Hazard
Other

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2321-2014.

These ricotta cheese products were manufactured from loads of whey protein concentrate that tested positive for beta lactam residues.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2321-2014.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Miceli Dairy Products Co or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2321-2014.

Miceli Dairy Products Co

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Miceli Dairy Products Co Recall FAQ

Miceli Dairy Products Co is the subject of a dairy safety report: Part Skim Ricotta cheese: SYSCO Imperial Ricotta Cheese packaged in 5 pound tubs and Sargento Part-Skim Ricotta Natural Cheese and Miceli.... The notice was published on June 19, 2014 by the U.S. Food and Drug Administration (FDA). Approximately 357 units are potentially affected.